Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent.

Deeb D, Gao X, Liu Y, Varma NR, Arbab AS, Gautam SC.

Molecules. 2013 Mar 13;18(3):3250-65. doi: 10.3390/molecules18033250.

2.
3.

Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity.

Deeb D, Gao X, Liu Y, Kim SH, Pindolia KR, Arbab AS, Gautam SC.

Biochem Biophys Res Commun. 2012 Jun 15;422(4):561-7. doi: 10.1016/j.bbrc.2012.05.024. Epub 2012 May 16.

4.

Telomerase reverse transcriptase (TERT) is a therapeutic target of oleanane triterpenoid CDDO-Me in prostate cancer.

Liu Y, Gao X, Deeb D, Arbab AS, Gautam SC.

Molecules. 2012 Dec 11;17(12):14795-809. doi: 10.3390/molecules171214795.

5.

Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism.

Deeb D, Gao X, Jiang H, Janic B, Arbab AS, Rojanasakul Y, Dulchavsky SA, Gautam SC.

Biochem Pharmacol. 2010 Feb 1;79(3):350-60. doi: 10.1016/j.bcp.2009.09.006. Epub 2009 Sep 24.

6.

ROS mediate proapoptotic and antisurvival activity of oleanane triterpenoid CDDO-Me in ovarian cancer cells.

Gao X, Liu Y, Deeb D, Liu P, Liu A, Arbab AS, Gautam SC.

Anticancer Res. 2013 Jan;33(1):215-21.

7.

Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.

Jutooru I, Chadalapaka G, Abdelrahim M, Basha MR, Samudio I, Konopleva M, Andreeff M, Safe S.

Mol Pharmacol. 2010 Aug;78(2):226-36. doi: 10.1124/mol.110.064451. Epub 2010 May 20. Erratum in: Mol Pharmacol. 2011 Feb;79(2):336.

8.

Synthetic oleanane triterpenoid, CDDO-Me, induces apoptosis in ovarian cancer cells by inhibiting prosurvival AKT/NF-κB/mTOR signaling.

Gao X, Liu Y, Deeb D, Arbab AS, Guo AM, Dulchavsky SA, Gautam SC.

Anticancer Res. 2011 Nov;31(11):3673-81.

10.

Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.

Deeb D, Gao X, Jiang H, Dulchavsky SA, Gautam SC.

Prostate. 2009 Jun 1;69(8):851-60. doi: 10.1002/pros.20937.

11.

Induction of Apoptosis in Pancreatic Cancer Cells by CDDO-Me Involves Repression of Telomerase through Epigenetic Pathways.

Deeb D, Brigolin C, Gao X, Liu Y, Pindolia KR, Gautam SC.

J Carcinog Mutagen. 2014 May 31;5:177.

12.

Role of reactive oxygen species (ROS) in CDDO-Me-mediated growth inhibition and apoptosis in colorectal cancer cells.

Gao X, Deeb D, Liu P, Liu Y, Arbab-Ali S, Dulchavsky SA, Gautam SC.

J Exp Ther Oncol. 2011;9(2):119-27.

13.

The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection.

Tran TA, McCoy MK, Sporn MB, Tansey MG.

J Neuroinflammation. 2008 May 12;5:14. doi: 10.1186/1742-2094-5-14.

15.

Oleanane triterpenoid CDDO-Me inhibits Akt activity without affecting PDK1 kinase or PP2A phosphatase activity in cancer cells.

Liu Y, Gao X, Deeb D, Gautam SC.

Biochem Biophys Res Commun. 2012 Jan 6;417(1):570-5. doi: 10.1016/j.bbrc.2011.12.007. Epub 2011 Dec 8.

16.
17.
20.

CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB signaling proteins in prostate cancer cells.

Deeb D, Gao X, Dulchavsky SA, Gautam SC.

Anticancer Res. 2007 Sep-Oct;27(5A):3035-44.

Supplemental Content

Support Center